• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨茶碱输注对X综合征患者运动能力的影响。

The effect of aminophylline infusion on the exercise capacity in patients with syndrome X.

作者信息

Yeşildağ O, Yazici M, Yilmaz O, Uçar R, Sağkan O

机构信息

University of Ondokuz Mayis, Faculty of Medicine, Dept. of Cardiology, Samsun, Turkey.

出版信息

Acta Cardiol. 1999 Dec;54(6):335-7.

PMID:10672289
Abstract

Aminophylline was known to decrease effort angina and ischaemia in patients with coronary artery disease and stable angina. This effect has been explained by the antagonization of the vasodilatation caused by adenosine and the prevention of the transmural myocardial maldistribution (steal phenomenon). In this study, treadmill exercise tests (with Bruce protocol) were performed in 14 patients (11 women, 3 men, mean age 51 +/- 9.9 years) diagnosed with syndrome X (typical anginal chest pain, abnormal stress test, normal coronary angiography) before (basal condition) and after the acute i.v. aminophylline infusion (total dosage 6 mg/kg within 15 minutes). It was shown that aminophylline lengthened the time before the occurrence of ischaemia in patients with syndrome X by increasing the ischaemia threshold in spite of the occurrence of tachycardia but it had no effect on the total exercise duration. Aminophylline infusion also exerted a beneficial effect on exercise-induced chest pain. It has been suggested that the role of the adenosine receptor could be important in the pathogenesis of syndrome X.

摘要

已知氨茶碱可减轻冠状动脉疾病和稳定型心绞痛患者的劳力性心绞痛及缺血症状。这种作用被解释为对腺苷引起的血管舒张的拮抗作用以及对跨壁心肌分布不均(窃血现象)的预防。在本研究中,对14例被诊断为X综合征(典型心绞痛胸痛、运动试验异常、冠状动脉造影正常)的患者(11名女性,3名男性,平均年龄51±9.9岁)进行了跑步机运动试验(采用布鲁斯方案),分别在急性静脉输注氨茶碱(15分钟内总剂量6mg/kg)之前(基础状态)和之后进行。结果显示,尽管出现了心动过速,但氨茶碱通过提高缺血阈值延长了X综合征患者缺血发生前的时间,但对总运动持续时间没有影响。氨茶碱输注对运动诱发的胸痛也有有益作用。有人提出腺苷受体在X综合征的发病机制中可能起重要作用。

相似文献

1
The effect of aminophylline infusion on the exercise capacity in patients with syndrome X.氨茶碱输注对X综合征患者运动能力的影响。
Acta Cardiol. 1999 Dec;54(6):335-7.
2
Different effects of acute administration of aminophylline and nitroglycerin on exercise capacity in patients with syndrome X.
Am J Cardiol. 1996 Jul 1;78(1):88-92. doi: 10.1016/s0002-9149(96)00231-7.
3
Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X).口服氨茶碱对心绞痛且冠状动脉造影正常患者(心脏X综合征)的影响。
Heart. 1997 Jun;77(6):523-6. doi: 10.1136/hrt.77.6.523.
4
[Increase in tolerance to physical effort in patients with X syndrome after acute administration of aminophylline].
Medicina (Firenze). 1989 Apr-Jun;9(2):173-5.
5
Effects of short-term aminophylline administration on cardiac functional reserve in patients with syndrome X.
J Am Coll Cardiol. 1995 Jun;25(7):1547-51. doi: 10.1016/0735-1097(95)00097-n.
6
Improved exercise capacity with acute aminophylline administration in patients with syndrome X.
J Am Coll Cardiol. 1989 Nov 15;14(6):1450-3. doi: 10.1016/0735-1097(89)90380-x.
7
Exercise capacity after acute aminophylline administration in angina pectoris.心绞痛患者急性给予氨茶碱后的运动能力
Am J Cardiol. 1989 Jan 1;63(1):14-6. doi: 10.1016/0002-9149(89)91067-9.
8
Role of adenosine in pathogenesis of syndrome X: assessment with coronary hemodynamic measurements and thallium-201 myocardial single-photon emission computed tomography.
J Am Coll Cardiol. 1996 Oct;28(4):890-6. doi: 10.1016/s0735-1097(96)00271-9.
9
Improvement of exercise-induced ischaemia and myocardial perfusion after aminophylline.
Coron Artery Dis. 1996 Jan;7(1):69-73.
10
Effects of bamiphylline on exercise testing in patients with syndrome X.
G Ital Cardiol. 1997 Jan;27(1):50-4.

引用本文的文献

1
Clinical aspects of ischemia with no obstructive coronary artery disease (INOCA).无阻塞性冠状动脉疾病(INOCA)的缺血的临床方面。
Am Heart J Plus. 2024 Jan;37. doi: 10.1016/j.ahjo.2023.100352. Epub 2023 Dec 6.
2
Updates on Pharmacologic Management of Microvascular Angina.微血管性心绞痛的药物治疗进展。
Cardiovasc Ther. 2022 Oct 25;2022:6080258. doi: 10.1155/2022/6080258. eCollection 2022.
3
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review.揭示冠状动脉血管舒缩障碍治疗选择的曙光:系统评价。
Cardiovasc Drugs Ther. 2024 Feb;38(1):151-161. doi: 10.1007/s10557-022-07351-x. Epub 2022 Jun 9.
4
Vasomotor Dysfunction in Patients with Ischemia and Non-Obstructive Coronary Artery Disease: Current Diagnostic and Therapeutic Strategies.缺血性和非阻塞性冠状动脉疾病患者的血管舒缩功能障碍:当前的诊断和治疗策略
Biomedicines. 2021 Nov 26;9(12):1774. doi: 10.3390/biomedicines9121774.
5
Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair-A Systematic Review.血管生成 CD34 干细胞治疗在冠状动脉微血管修复中的系统评价。
Cells. 2021 May 8;10(5):1137. doi: 10.3390/cells10051137.
6
Treatment of coronary microvascular dysfunction.冠状动脉微血管功能障碍的治疗。
Cardiovasc Res. 2020 Mar 1;116(4):856-870. doi: 10.1093/cvr/cvaa006.
7
Women's health: making cardiovascular disease real.女性健康:正视心血管疾病
Curr Opin Cardiol. 2018 Sep;33(5):506-513. doi: 10.1097/HCO.0000000000000544.
8
Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease).为何名称对女性至关重要:MINOCA/INOCA(心肌梗死/缺血且无阻塞性冠状动脉疾病)
Clin Cardiol. 2018 Feb;41(2):185-193. doi: 10.1002/clc.22894. Epub 2018 Mar 2.
9
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.缺血与无阻塞性冠状动脉疾病(INOCA):为未来十年制定循证疗法与研究议程
Circulation. 2017 Mar 14;135(11):1075-1092. doi: 10.1161/CIRCULATIONAHA.116.024534.
10
Coronary Microvascular Dysfunction - Epidemiology, Pathogenesis, Prognosis, Diagnosis, Risk Factors and Therapy.冠状动脉微血管功能障碍——流行病学、发病机制、预后、诊断、危险因素及治疗
Circ J. 2016 Dec 22;81(1):3-11. doi: 10.1253/circj.CJ-16-1002. Epub 2016 Nov 29.